Loading
Bacteremia · Observational Study
ClinicalTrials.gov · August 4, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed observational study registration evaluating emergency medicine pharmacist involvement in blood culture review after ED discharge, focusing on time to review and patient notification. No results have been posted in this registry record, so the efficacy, safety, or clinical impact of the intervention cannot be determined from this source.
Observational. Bacteremia; age from 18 Years; accepts healthy volunteers. Intervention: Emergency medicine pharmacist (EMPs); Charge nurse (CN's). n = 146. 1 site: United States.
This is a completed observational study registration evaluating emergency medicine pharmacist involvement in blood culture review after ED discharge, focusing on time to review and patient notification. No results have been posted in this registry record, so the efficacy, safety, or clinical impact of the intervention cannot be determined from this source.
No information on how pharmacist intervention was operationalized, timing, or adherence to the protocol.
The source did not state who this applies to in practice.
This is a completed observational registry record with no results posted; it documents a planned study of pharmacist impact on blood culture review but reports no outcome data.
As stated by the source record.
Quoted from the source exactly as published.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT07486362). This is a study registration, not published results. Lead sponsor: Methodist Health System. Recruitment status: COMPLETED. Study type: OBSERVATIONAL. Enrollment: 146 participants (ACTUAL). Conditions: Bacteremia. Interventions: OTHER: No Intervention. Primary outcome measures: Time from an actionable positive blood culture to the time of review and/or patient notification. ult. , 18 months. Brief summary: Patients are commonly discharged from the Emergency Department(ED) with pending blood culture results. Blood cultures can take up to 48 hours to become positive which is why it is important to notify patients with true positive cultures as soon as possible. Delay in notification can lead to other serious complications such as sepsis, septic shock, and death. The American College of Emergency Physicians states pharmacists serve a critical role in ensuring efficient, safe, and effective medication use in the ED and advocates for health systems to support dedicated roles for pharmacists within the ED. Pharmacists help to decrease the workload on the healthcare team, especially in the ED where there is high volume and acuity.Emergency medicine pharmacist (EMP) play a significant role in the optimization of therapy, medication safety, and reducing costs. There is strong evidence for the positive impact EMPs have on microbiological culture review. Overall, pharmacist review of late cultures results in higher rates of appropriate antimicrobial therapy and decreased missed interventions.These prior studies focused on the review of microbiological tests, including sexually transmitted infections, urine, and wound cultures; however, there was limited data to support the role of pharmacists evaluating late blood culture results.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.